Simplify Asset Management Inc. Has $6.93 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Simplify Asset Management Inc. increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 615.8% during the second quarter, Holdings Channel reports. The fund owned 13,600 shares of the healthcare conglomerate’s stock after acquiring an additional 11,700 shares during the quarter. UnitedHealth Group comprises about 0.5% of Simplify Asset Management Inc.’s holdings, making the stock its 15th biggest holding. Simplify Asset Management Inc.’s holdings in UnitedHealth Group were worth $6,926,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in UNH. Aveo Capital Partners LLC grew its holdings in UnitedHealth Group by 23.8% in the 4th quarter. Aveo Capital Partners LLC now owns 2,164 shares of the healthcare conglomerate’s stock valued at $1,139,000 after buying an additional 416 shares in the last quarter. 9258 Wealth Management LLC raised its stake in UnitedHealth Group by 7.3% in the 4th quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock worth $2,250,000 after purchasing an additional 290 shares in the last quarter. Gryphon Financial Partners LLC grew its position in shares of UnitedHealth Group by 80.9% during the 4th quarter. Gryphon Financial Partners LLC now owns 6,220 shares of the healthcare conglomerate’s stock worth $3,275,000 after purchasing an additional 2,782 shares in the last quarter. TrinityPoint Wealth LLC grew its position in UnitedHealth Group by 102.8% during the fourth quarter. TrinityPoint Wealth LLC now owns 14,774 shares of the healthcare conglomerate’s stock worth $7,778,000 after buying an additional 7,489 shares in the last quarter. Finally, Quest Partners LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at $668,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on UNH shares. Barclays upped their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. TD Cowen raised their target price on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Truist Financial raised their price objective on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Finally, Robert W. Baird raised their price target on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. One research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $614.17.

UnitedHealth Group Trading Down 0.6 %

UNH opened at $577.10 on Friday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The stock has a market cap of $532.91 billion, a PE ratio of 35.28, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. The company has a fifty day moving average of $575.84 and a 200-day moving average of $519.83. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.14 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Insider Activity at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.